Opinion: Understanding the FDA’s Take on Cannabidiol

If you’re a cancer patient, you are no stranger to pain or, most likely, to opioids.

One therapy, cannabis, has long been discussed as a legitimate therapeutic alternative — but has been caught up in the debate over its nonmedical “recreational” uses, along with its cousin, cannabidiol (CBD). Regardless of where you may stand on these issues, we are moving forward. The times they are a-changing.

But the reality is more complicated than the soundbites, and the reality is that the situation is very complicated. Nowhere is this more obvious or urgent than when it comes to the role and responsibilities of the Food and Drug Administration and its regulation of CBD.

In December of last year, the Agriculture Improvement Act of 2018 (“the Farm Bill”) was signed into law. Among other things, this new law changed certain federal authorities relating to the production and marketing of hemp. These changes include removing hemp from

... read more at: https://www.cancertherapyadvisor.com/home/cancer-topics/general-oncology/opinion-understanding-the-fdas-take-on-cannabidiol/